BACKGROUND: During the remodeling process after myocardial infarction (MI), the expression of proinflammatory cytokines is enhanced in the myocardium. However, only a few clinical studies have been conducted on cytokine involvement in left ventricular (LV) remodeling after MI. HYPOTHESIS: Circulating proinflammatory cytokines may be involved in LV remodeling in patients with reperfused MI. METHODS: We studied 25 patients with acute anterior MI who had undergone coronary reperfusion therapy, and 10 normal control subjects with no cardiac disease. In all patients, LV ejection fraction, end-diastolic volume index (EDVI), and end-systolic volume index (ESVI) were determined using left ventriculography at the acute phase and 6 months after onset. The delta EDVI and delta ESVI were calculated as the value of LV volume reduction, suggesting LV reverse remodeling. Serum levels of interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha were measured using enzyme-linked immunosorbent assay. RESULTS: Serum levels of IL-6 and TNF-alpha at the acute phase were significantly higher in patients with MI than in control subjects (both p < 0.05). The IL-6 levels correlated well negatively with delta EDVI (r = 0.779, p = 0.039), whereas no correlation was found for TNF-alpha. According to multivariate analysis, IL-6 at the acute phase was a significant independent predictor for LV remodeling after reperfused MI (p = 0.007). CONCLUSIONS: Circulating IL-6 levels correlated closely with LV geometric changes during the remodeling process in patients with reperfused MI. Our study addresses the usefulness of another marker for LV remodeling after MI.
BACKGROUND: During the remodeling process after myocardial infarction (MI), the expression of proinflammatory cytokines is enhanced in the myocardium. However, only a few clinical studies have been conducted on cytokine involvement in left ventricular (LV) remodeling after MI. HYPOTHESIS: Circulating proinflammatory cytokines may be involved in LV remodeling in patients with reperfused MI. METHODS: We studied 25 patients with acute anterior MI who had undergone coronary reperfusion therapy, and 10 normal control subjects with no cardiac disease. In all patients, LV ejection fraction, end-diastolic volume index (EDVI), and end-systolic volume index (ESVI) were determined using left ventriculography at the acute phase and 6 months after onset. The delta EDVI and delta ESVI were calculated as the value of LV volume reduction, suggesting LV reverse remodeling. Serum levels of interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha were measured using enzyme-linked immunosorbent assay. RESULTS: Serum levels of IL-6 and TNF-alpha at the acute phase were significantly higher in patients with MI than in control subjects (both p < 0.05). The IL-6 levels correlated well negatively with delta EDVI (r = 0.779, p = 0.039), whereas no correlation was found for TNF-alpha. According to multivariate analysis, IL-6 at the acute phase was a significant independent predictor for LV remodeling after reperfused MI (p = 0.007). CONCLUSIONS: Circulating IL-6 levels correlated closely with LV geometric changes during the remodeling process in patients with reperfused MI. Our study addresses the usefulness of another marker for LV remodeling after MI.
Authors: M Jacobs; S Staufenberger; U Gergs; K Meuter; K Brandstätter; M Hafner; G Ertl; W Schorb Journal: J Mol Cell Cardiol Date: 1999-11 Impact factor: 5.000
Authors: I Jeremias; C Kupatt; A Martin-Villalba; H Habazettl; J Schenkel; P Boekstegers; K M Debatin Journal: Circulation Date: 2000-08-22 Impact factor: 29.690
Authors: T Ohtsuka; M Hamada; G Hiasa; O Sasaki; M Suzuki; Y Hara; Y Shigematsu; K Hiwada Journal: J Am Coll Cardiol Date: 2001-02 Impact factor: 24.094
Authors: U Ikeda; F Ohkawa; Y Seino; K Yamamoto; Y Hidaka; T Kasahara; T Kawai; K Shimada Journal: J Mol Cell Cardiol Date: 1992-06 Impact factor: 5.000
Authors: Adelaide M Arruda-Olson; Véronique L Roger; High S Chai; Mariza de Andrade; Brooke L Fridley; Julie M Cunningham; Sherine E Gabriel; Suzette J Bielinski Journal: Mayo Clin Proc Date: 2011-11 Impact factor: 7.616
Authors: Germán E González; Nour-Eddine Rhaleb; Martin A D'Ambrosio; Pablo Nakagawa; Yunhe Liu; Pablo Leung; Xiangguo Dai; Xiao-Ping Yang; Edward L Peterson; Oscar A Carretero Journal: J Hypertens Date: 2015-01 Impact factor: 4.844
Authors: Jan Máchal; Monika Pávková-Goldbergová; Ota Hlinomaz; Ladislav Groch; Anna Vašků Journal: Medicine (Baltimore) Date: 2014-12 Impact factor: 1.889
Authors: Thomas Bochaton; Jules Lassus; Alexandre Paccalet; François Derimay; Gilles Rioufol; Cyril Prieur; Eric Bonnefoy-Cudraz; Claire Crola Da Silva; Hugo Bernelin; Camille Amaz; Sylvie Espanet; Charles de Bourguignon; Nathalie Dufay; Régine Cartier; Pierre Croisille; Michel Ovize; Nathan Mewton Journal: PLoS One Date: 2021-01-28 Impact factor: 3.240